iShares Health Innovation Active ETF (NYSEARCA:BMED) Sees Significant Increase in Short Interest

iShares Health Innovation Active ETF (NYSEARCA:BMED) was the target of a large increase in short interest during the month of June. As of June 15th, there was short interest totaling 1,472 shares, an increase of 159.2% from the May 31st total of 568 shares. Approximately 0.4% of the shares of the company are sold short. Based on an average daily trading volume, of 1,249 shares, the short-interest ratio is presently 1.2 days.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in iShares Health Innovation Active ETF stock. Sunbelt Securities Inc. purchased a new stake in shares of iShares Health Innovation Active ETF (NYSEARCA:BMED) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 11,612 shares of the company’s stock, valued at approximately $352,000. Sunbelt Securities Inc. owned 3.63% of iShares Health Innovation Active ETF as of its most recent SEC filing.

iShares Health Innovation Active ETF Price Performance

NYSEARCA BMED opened at $30.58 on Monday. The stock has a market capitalization of $11.01 million, a price-to-earnings ratio of 24.91 and a beta of 0.75. iShares Health Innovation Active ETF has a 1-year low of $24.50 and a 1-year high of $32.19. The business’s fifty day moving average price is $28.36 and its 200-day moving average price is $29.55.

About iShares Health Innovation Active ETF

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.